Cargando…
Glycyrrhizic Acid for COVID-19: Findings of Targeting Pivotal Inflammatory Pathways Triggered by SARS-CoV-2
Background: Coronavirus disease 2019 (COVID-19) is now a worldwide public health crisis. The causative pathogen is severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Novel therapeutic agents are desperately needed. Because of the frequent mutations in the virus and its ability to cause cy...
Autores principales: | Zheng, Wenjiang, Huang, Xiufang, Lai, Yanni, Liu, Xiaohong, Jiang, Yong, Zhan, Shaofeng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8223069/ https://www.ncbi.nlm.nih.gov/pubmed/34177566 http://dx.doi.org/10.3389/fphar.2021.631206 |
Ejemplares similares
-
Exploring the Pivotal Immunomodulatory and Anti-Inflammatory Potentials of Glycyrrhizic and Glycyrrhetinic Acids
por: Richard, Seidu A.
Publicado: (2021) -
Advances in the roles of glycyrrhizic acid in cancer therapy
por: Zhang, Yuqian, et al.
Publicado: (2023) -
Glycyrrhizic acid alleviates bleomycin-induced pulmonary fibrosis in rats
por: Gao, Lili, et al.
Publicado: (2015) -
Antiviral Activity of Isoimperatorin Against Influenza A Virus in vitro and its Inhibition of Neuraminidase
por: Lai, Yanni, et al.
Publicado: (2021) -
Analysis of the network pharmacology and the structure-activity relationship of glycyrrhizic acid and glycyrrhetinic acid
por: Ni, Qingqiang, et al.
Publicado: (2022)